Sarepta Therapeutics (SRPT) Goodwill & Intangibles (2010 - 2026)
Sarepta Therapeutics' quarterly Goodwill & Intangibles came in at $31.4 million in Q1 2026, up 19.79% year-on-year from $26.2 million in Q1 2025, and up 8.41% quarter-over-quarter from $28.9 million in Q4 2025.
Sarepta Therapeutics has reported Goodwill & Intangibles for 17 years, with the latest figure at $31.4 million in Q1 2026.
- For the quarter ending Q1 2026, Goodwill & Intangibles rose 19.79% year-over-year to $31.4 million; the trailing twelve-month figure through Mar 2026 stood at $31.4 million (up 19.79% YoY), and the FY2025 full-year result was $28.9 million, up 7.67% from the prior year.
- Goodwill & Intangibles for Q1 2026 stood at $31.4 million, up from $28.9 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $31.4 million in Q1 2026, with the low at $7.2 million in Q1 2023.
- Average Goodwill & Intangibles over 5 years is $21.9 million, with a median of $26.2 million recorded in 2025.
- Year-over-year, Goodwill & Intangibles plunged 64.35% in 2022 and surged 301.86% in 2024.
- Tracing SRPT's Goodwill & Intangibles over 5 years: stood at $7.6 million in 2022, then soared by 203.51% to $23.0 million in 2023, then gained by 16.9% to $26.9 million in 2024, then grew by 7.67% to $28.9 million in 2025, then climbed by 8.41% to $31.4 million in 2026.
- The last three Goodwill & Intangibles figures came in at $31.4 million (Q1 2026), $28.9 million (Q4 2025), and $29.7 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Sarepta Therapeutics | 1.86 Bn | 1.17 Bn | 291.52 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 31.38 Mn |
| Dec 31, 2025 | 28.95 Mn |
| Sep 30, 2025 | 29.68 Mn |
| Jun 30, 2025 | 30.52 Mn |
| Mar 31, 2025 | 26.20 Mn |
| Dec 31, 2024 | 26.89 Mn |
| Sep 30, 2024 | 27.57 Mn |
| Jun 30, 2024 | 28.25 Mn |
| Mar 31, 2024 | 28.93 Mn |
| Dec 31, 2023 | 23.00 Mn |
| Sep 30, 2023 | 19.50 Mn |
| Jun 30, 2023 | 18.02 Mn |
| Mar 31, 2023 | 7.20 Mn |
| Dec 31, 2022 | 7.58 Mn |
| Sep 30, 2022 | 13.06 Mn |
| Jun 30, 2022 | 13.06 Mn |
| Mar 31, 2022 | 13.33 Mn |
| Dec 31, 2021 | 21.25 Mn |
| Sep 30, 2021 | 14.20 Mn |
| Jun 30, 2021 | 14.11 Mn |
| Mar 31, 2021 | 14.12 Mn |
| Dec 31, 2020 | 20.84 Mn |
| Sep 30, 2020 | 13.34 Mn |
| Jun 30, 2020 | 13.11 Mn |
| Mar 31, 2020 | 12.81 Mn |
| Dec 31, 2019 | 18.00 Mn |
| Sep 30, 2019 | 11.98 Mn |
| Jun 30, 2019 | 11.83 Mn |
| Mar 31, 2019 | 11.78 Mn |
| Dec 31, 2018 | 11.57 Mn |
| Sep 30, 2018 | 15.32 Mn |
| Jun 30, 2018 | 14.86 Mn |
| Mar 31, 2018 | 14.47 Mn |
| Dec 31, 2017 | 6.60 Mn |
| Sep 30, 2017 | 14.03 Mn |
| Jun 30, 2017 | 7.80 Mn |
| Mar 31, 2017 | 7.68 Mn |
| Dec 31, 2016 | 8.08 Mn |
| Sep 30, 2016 | 11.17 Mn |
| Jun 30, 2016 | 6.99 Mn |
| Mar 31, 2016 | 6.73 Mn |
| Dec 31, 2015 | 6.64 Mn |
| Sep 30, 2015 | 6.12 Mn |
| Jun 30, 2015 | 6.02 Mn |
| Mar 31, 2015 | 5.84 Mn |
| Dec 31, 2014 | 5.89 Mn |
| Sep 30, 2014 | 5.69 Mn |
| Jun 30, 2014 | 5.39 Mn |
| Mar 31, 2014 | 5.22 Mn |
| Dec 31, 2013 | 5.04 Mn |
| Sep 30, 2013 | 5.23 Mn |
| Jun 30, 2013 | 5.19 Mn |
| Mar 31, 2013 | 4.88 Mn |
| Dec 31, 2012 | 4.91 Mn |
| Mar 31, 2012 | 4.70 Mn |
| Dec 31, 2011 | 4.76 Mn |
| Sep 30, 2011 | 4.70 Mn |
| Jun 30, 2011 | 4.46 Mn |
| Dec 31, 2010 | 3.98 Mn |